Appointment and Re-designation of Dr. Amar Agarwal, Chairman and Non-Executive Director of the Company, as…
As filed · Appointment and Re-designation of Dr. Amar Agarwal, Chairman and Non-Executive Director of the Company, as the Executive Chairman (Whole-Time Director) of the Company
What happened
FactAppointment and Re-designation of Dr. Amar Agarwal, Chairman and Non-Executive Director of the Company, as the Executive Chairman (Whole-Time Director) of the Company. the Limited Review Report issued by M/s. S.R. The terms and conditions of the aforesaid appointment cum re-designation and the remuneration.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Debt
Revisedfinance cost actually moved from about close to INR24.7 crores in Q1 of last year to about close to INR23.5 crores.
the interest on deferred acquisition payable was about close to INR6.8 crores in corresponding quarter of last year, which dropped down to about INR3.6 crores.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- We expect to clock 20% plus revenue growth in FY '26, driven by strengthening presence in existing micro-marke (management committed by FY26)
- We also expect the profit after tax numbers to rise by 35% plus. (management committed by FY26)
Evidence
- Board Meeting Outcome for Consolidated And Standalone Unaudited Financial Results For The Quarter and Half Year Ended September 30, 2026 And Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- DIRECTOR_CHANGE base 26; +2 corroborating keywords; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%